Beneficial effects of ascorbic acid on preimplantation mouse embryos after exposure to cyclophosphamide in vivo.
To study mechanisms of embryotoxicity in early pregnancy, we have evaluated the genotoxic and embryolethal effects of ascorbic acid (AA) alone or in combination with cyclophosphamide (CPA). Female mice were exposed on day 3 of pregnancy. Embryotoxicity was investigated at term and genotoxicity shortly after treatment using the chromosomal aberration test and the sister chromatid exchange (SCE) assay as sensitive end points. Additionally, cytotoxic effects were determined by a proliferation test. AA was not found to be embryotoxic, cytotoxic, or genotoxic when given alone. In combination with 10 mg/kg CPA, however, which induced 50% aberrant metaphases, 100% increase SCE frequency, and a strong inhibition of cell proliferation, AA in a dose range of 25-1,600 mg/kg did not change SCE and proliferation, but reduced the rate of aberrant metaphases significantly. This anticlastogenic effect was clearly correlated to a beneficial effect on embryolethality at term when 200 mg/kg ascorbic acid was given in combination with 40 mg/kg CPA. The results suggest that during early pregnancy AA is not genotoxic even at so-called megadoses doses, but it seems to protect early embryos against damage induced by genotoxic agents like CPA.
Vogel
R
R
Max von Pettenkofer-Institute, Federal Health Office, Berlin, Federal Republic of Germany.
Spielmann
H
H
D000818:Animals; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D001755:Blastocyst / Q000187:drug effects; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D004305:Dose-Response Relationship, Drug; D004622:Embryo, Mammalian / Q000187:drug effects*; D047108:Embryonic Development; D005260:Female; D005333:Fetus; D005865:Gestational Age; D066298:In Vitro Techniques; D008431:Maternal-Fetal Exchange; D051379:Mice; D009152:Mutagenicity Tests; D009153:Mutagens; D011247:Pregnancy
D009153:Mutagens; D003520:Cyclophosphamide; D001205:Ascorbic Acid